Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination Of FEZ1/LZTS1 Expression As A Predictor Of Response To Taxol

NCT00898690 is registered in ClinicalTrials.gov with Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University as lead sponsor.

NCT NCT00898690
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00898690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination Of FEZ1/LZTS1 Expression As A Predictor Of Response To Taxol
Lead sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2003
Completion date
Not reported
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer